2020
DOI: 10.1016/j.psj.2020.06.014
|View full text |Cite
|
Sign up to set email alerts
|

Current status of vaccine research, development, and challenges of vaccines for Mycoplasma gallisepticum

Abstract: Mycoplasma gallisepticum ( MG ) is an important avian pathogen that causes significant economic losses in the poultry industry. Surprisingly, the limited protection and adverse reactions caused by the vaccines, including live vaccines, bacterin-based (killed) vaccines, and recombinant viral vaccines is still a major concern. Mycoplasma gallisepticum strains vary in infectivity and virulence and infection may sometimes unapparent and goes undetected. Alth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
28
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(32 citation statements)
references
References 118 publications
0
28
0
Order By: Relevance
“…6.6.3. Mycoplasma gallisepticum Mycoplasma gallisepticum (MG), an avian pathogen, belonging to the class of Mollicutes, is known as the primary etiological agent of chicken chronic respiratory disease, causing inflammatory damage of the host respiratory system [281]. Initially, when live MG bacteria were incubated with primary chicken tracheal epithelial cells, inflammatory NF-κB-dependent genes were upregulated, while an NF-κB inhibitor abrogated the inflammatory response [282].…”
Section: Salmonellamentioning
confidence: 99%
“…6.6.3. Mycoplasma gallisepticum Mycoplasma gallisepticum (MG), an avian pathogen, belonging to the class of Mollicutes, is known as the primary etiological agent of chicken chronic respiratory disease, causing inflammatory damage of the host respiratory system [281]. Initially, when live MG bacteria were incubated with primary chicken tracheal epithelial cells, inflammatory NF-κB-dependent genes were upregulated, while an NF-κB inhibitor abrogated the inflammatory response [282].…”
Section: Salmonellamentioning
confidence: 99%
“…The control strategies for mycoplasmoses vary geographically and include prophylaxis and the use of antibiotics, vaccines, and ultimately, culling. In the context of increasing antibiotic resistance (14) and the relative lack of effective vaccines, better knowledge of the molecular basis of virulence and host-pathogen interactions is required to improve curative protocols and design more efficient vaccines (13, 15). However, the lack of efficient genome engineering tools for many mycoplasmas, including the three species listed above, limits functional genomics approaches and hinders efforts toward the production of rationally designed vaccines.…”
Section: Introductionmentioning
confidence: 99%
“…Goose breeding is a promising and rapidly developing branch of poultry farming in many countries of the world, and the production of high-quality and safe products requires observance of the general and specific prevention measures of not developing of infectious and mass non-infectious diseases at goose-breeding farms. Competent formation of technological schemes of veterinary treatments will ensure high efficiency of enterprises' veterinary services [1].…”
Section: Introductionmentioning
confidence: 99%